Today, we shift our focus to managing advanced and recurrent rectal cancer. We will outline the systemic therapy options for metastatic colorectal cancer, including the roles of specific chemotherapies and biologics based on molecular markers. We'll then discuss the critical management of lateral pelvic lymph nodes. Finally, we'll delve into the complex, yet often life-saving, principles of pelvic re-irradiation for recurrent rectal cancer.